Indian drug and medical services firm PharmEasy may lay off hundreds of employees, according to sources. This move is being seen as part of a drive by the unicorn company towards profitability via cost-savings and consolidation, as funds dry up, they said.
“The company is facing a funding crunch due to which it is laying off staff,” said a person familiar with the matter. “It was trying to raise funding from Goldman Sachs, but that deal didn’t materialise.”
The company has a total workforce of about 1500.
A query to PharmEasy founders about this development remained unanswered till the time

)